Medical News

RSS

Toshiba to showcase episode-based care solutions at RSNA annual meeting

Containing costs while delivering high-quality, effective care is a directive of healthcare reform. With episode-based care as part of the reform mandate, many healthcare providers are uncertain about its effect on both patient outcomes and their bottom-line. Toshiba America Medical Systems, Inc. is partnering with leading healthcare providers to develop solutions to address episode-based care by effectively utilizing patient-focused imaging technology and a multidisciplinary collaborative approach to treatment.

29 Nov 2010

Ziehm Imaging launches SmartVascular software solution for vascular surgery

Ziehm Imaging's intuitive SmartVascular software considerably simplifies imaging in vascular surgery. It introduces an entirely new workflow for fast results. This solution raises efficiency levels, eliminates interim C-arm operating steps and automates the imaging processes. SmartVascular is compatible with all Ziehm Vision C-arms and tailored to vascular procedures.

29 Nov 2010

Amarin reports top-line results from AMR101 Phase 3 trial for treatment of high triglycerides

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported positive, statistically significant top-line results from the MARINE study, its first Phase 3 clinical trial of lead drug candidate AMR101.

29 Nov 2010

AMAG updates product label of Feraheme Injection

AMAG Pharmaceuticals, Inc. today announced that the company has reached agreement with the U.S. Food and Drug Administration (FDA) regarding an update to the product label for Feraheme (ferumoxytol) Injection for intravenous (IV) use.

29 Nov 2010

New 'canSAR' cancer drug discovery database launched

A powerful new cancer drug discovery database has been launched to speed up the process of bringing drugs from 'bench to bedside'.

29 Nov 2010

NovaBay announces meeting with FDA to discuss Aganocide compound for impetigo

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces a successful meeting with the US Food and Drug Administration (FDA) to discuss the Company's clinical development of its Aganocide compound NVC-422, intended for use in the treatment of impetigo.

29 Nov 2010

QOI and Quantel enter co-promotion agreement for Activis PDT Lasers

QLT Inc. today announced that its wholly-owned U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"), and Quantel Medical and its distributor, Quantel USA, Inc., have entered into a co-promotion agreement for the sale of Activis PDT Lasers used to activate Visudyne® during photodynamic therapy of primarily classic lesions in wet age-related macular degeneration (AMD). The lasers are manufactured by Quantel Medical and sold by Quantel USA, Inc. and will be promoted by both Quantel USA, Inc. and QOI's sales force to the retina community in the United States.

29 Nov 2010

Toshiba announces multi-center trial to evaluate Time-SLIP Renal MR Angiography

Non-contrast MR angiography provides clear, high-quality images and can be used as an effective tool for diagnosing renal artery stenosis. To illustrate non-contrast MRA's ability as a diagnostic tool for renal artery stenosis, Toshiba has announced a multi-center trial to establish the clinical value of non-contrast Renal MRA using Time-SLIP.

29 Nov 2010

NDSsi launches new DOME S10 diagnostic imaging display for mammography screening at RSNA 2010

A highly advanced 10MP diagnostic imaging display capable of showing two 5MP images for back-to-back chest wall reads has been launched by medical technology leader NDS Surgical Imaging (NDSsi). The new 30-inch widescreen Dome S10 supports 10-bit and 8-bit grayscale image data through industry standard interfaces, eliminating the need for proprietary libraries. Featuring non-reflective glass for higher-clarity viewing, and state-of-the-art 4096 x 2560 resolution, the S10 has raised the bar in optical performance in mammography screening.

29 Nov 2010

Accentia enters strategic agreement with Baxter to purchase Cytoxan drug

Accentia Biopharmaceuticals, Inc. today announced a strategic agreement with Baxter Healthcare Corporation to provide Accentia with the exclusive, worldwide right to purchase Baxter's cyclophosphamide, which is marketed under the brand name Cytoxan, for the treatment of designated autoimmune diseases including multiple sclerosis.

29 Nov 2010

Depressed and suicidal individuals linked to low levels of stress hormone cortisol

Depressed and suicidal individuals have low levels of the stress hormone cortisol in their blood and saliva. They also have substances in their spinal fluid that suggest there is increased inflammation in the brain. These findings could help to develop new methods for diagnosing and treating suicidal patients.

29 Nov 2010

Tongjitang files going-private statement on Schedule 13E-3 with SEC

Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it has filed a going-private transaction statement on Schedule 13E-3 with the United States Securities and Exchange Commission

29 Nov 2010

Baylor Health Care System receives $20 million to benefit transplantation initiatives

Baylor Health Care System Foundation announces that Annette C. and Harold C. Simmons have pledged $20 million to benefit transplantation initiatives within Baylor Health Care System. In recognition of this transformational gift, Baylor will rename the institute the Annette C. and Harold C. Simmons Transplant Institute.

29 Nov 2010

Olympic silver medallist to make fifth appearance at Bupa Great Edinburgh Cross Country

“I think what is important about cutting the international race to 4km is that it will also allow track stars who specialise over 1500m to take part, and there has been an encouraging response to the proposal”

29 Nov 2010

Affymax, Takeda to regulate peginesatide drug for treating anemia in CRF patients

Affymax, Inc. and Takeda Pharmaceutical Company Limited , today announced that following pre-New Drug Application (NDA) discussions with the U.S. Food and Drug Administration (FDA), the companies will move forward with their regulatory strategy for the investigational drug, peginesatide, for the treatment of anemia in chronic renal failure (CRF) patients on dialysis in the United States.

29 Nov 2010

Golden Valley acquires Digit-Pro and Cut Stop

Golden Valley Development, Inc. is pleased to announce that it has recently completed the acquisition of two new companies, each having a licensing agreement to manufacture and market a new patented technology.

29 Nov 2010

BioTime, CIRM enter agreement for GMP-grade hES cell lines

BioTime, Inc. today announced an agreement with the California Institute for Regenerative Medicine (CIRM) to make five clinical-grade human embryonic stem (hES) cell lines available to California-based researchers. CIRM is the stem cell agency created when California voters supported a $3 billion funding measure for stem cell-related research and clinical translation.

29 Nov 2010

SimpliClear Full braces solution can treat teeth misalignments

BioMers Pte Ltd, a portfolio company of Nanostart AG, has announced the initial market launch of its new flagship product line, the SimpliClear Full orthodontic system. These completely translucent dental braces may be used to treat patients even with severe misalignment of teeth which has, until now, only been possible with unsightly metal braces.

29 Nov 2010

HAL Allergy files MAA for PURETHAL Mites and SUBLIVAC FIX products at Paul-Ehrlich-Institute

HAL Allergy today announced that it has filed marketing authorization applications (MAA) for PURETHAL(R) Mites and SUBLIVAC(R) FIX Grasses, Trees, and Mites (incl. homologous group products) at the Paul-Ehrlich-Institute, the regulatory authority in Germany.

29 Nov 2010

QIAGEN to supply point-of-need molecular veterinary diagnostics for disease detection in emerging countries

QIAGEN has been selected to contribute to the fight against infectious diseases in animals in emerging countries by supplying an international pilot project associated with the United Nations with portable devices to perform ultra-fast molecular testing in the field.

From QIAGEN Manchester Limited 29 Nov 2010

Medical News

Toshiba to showcase episode-based care solutions at RSNA annual meeting

Ziehm Imaging launches SmartVascular software solution for vascular surgery

Amarin reports top-line results from AMR101 Phase 3 trial for treatment of high triglycerides

AMAG updates product label of Feraheme Injection

New 'canSAR' cancer drug discovery database launched

NovaBay announces meeting with FDA to discuss Aganocide compound for impetigo

QOI and Quantel enter co-promotion agreement for Activis PDT Lasers

Toshiba announces multi-center trial to evaluate Time-SLIP Renal MR Angiography

NDSsi launches new DOME S10 diagnostic imaging display for mammography screening at RSNA 2010

Accentia enters strategic agreement with Baxter to purchase Cytoxan drug

Depressed and suicidal individuals linked to low levels of stress hormone cortisol

Tongjitang files going-private statement on Schedule 13E-3 with SEC

Baylor Health Care System receives $20 million to benefit transplantation initiatives

Olympic silver medallist to make fifth appearance at Bupa Great Edinburgh Cross Country

Affymax, Takeda to regulate peginesatide drug for treating anemia in CRF patients

Golden Valley acquires Digit-Pro and Cut Stop

BioTime, CIRM enter agreement for GMP-grade hES cell lines

SimpliClear Full braces solution can treat teeth misalignments

HAL Allergy files MAA for PURETHAL Mites and SUBLIVAC FIX products at Paul-Ehrlich-Institute

QIAGEN to supply point-of-need molecular veterinary diagnostics for disease detection in emerging countries

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News